UK biomaterials company Modern Synthesis raises US$4.1M to build bacterial ‘bioweaving’ pilot facility to produce nanocellulose fiber from textile waste, starting up in Q3; process generates no waste, can replace animal-, petrol-based textiles, films

Sample article from our Chemicals Industry

LOS ANGELES , June 20, 2022 () –

UK-based Modern Synthesis, a biomaterials manufacturer, has raised US$4.1M to fund its bacterial ‘bioweaving’ technology, which produces nanocellulose fibers from textile waste, AgFunderNews reported June 1.

The company’s genetically modified bacteria feed on sugars from textile waste. The sugar is converted into nanocellulose, which the bacteria deposit onto robotically engineered scaffolds designed by the company’s technicians.

According to the company, it has already prototyped the upper portion of a shoe using their bioweaving process. The process takes roughly two weeks to complete.

Modern Synthesis plans to use the majority of its seed funding to establish a pilot manufacturing laboratory in London, which should be operating by Q3.

The primary source for this article is AgFunderNews, California, published on June 1, 2022. To read the original article, click here.


* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.